Metabolic genes in cancer: their roles in tumor progression and clinical implications.
暂无分享,去创建一个
Kounosuke Watabe | K. Watabe | A. Kobayashi | H. Okuda | Hiroshi Okuda | Aya Kobayashi | Eiji Furuta | E. Furuta
[1] Y. Yen,et al. ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage , 2008, Proceedings of the National Academy of Sciences.
[2] M. Birnbaum,et al. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. , 1987, Science.
[3] E. De Clercq,et al. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. , 1999, Biochemical pharmacology.
[4] M. Hendrix,et al. Role for glucose transporter 1 protein in human breast cancer , 2008, Pathology & Oncology Research.
[5] M. Hung,et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.
[6] Masaki Kobayashi,et al. Transport mechanism for L-lactic acid in human myocytes using human prototypic embryonal rhabdomyosarcoma cell line (RD cells). , 2005, Biological & pharmaceutical bulletin.
[7] GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer , 2003 .
[8] F. Kuhajda. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. , 2000, Nutrition.
[9] R. Gottlieb,et al. Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Spitz,et al. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. , 2007, Cancer research.
[11] S. Chirala,et al. Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[13] L. Aaltonen,et al. Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.
[14] Brian Keith,et al. Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.
[15] Y. Yazaki,et al. Expression of the GLUT1 glucose transporter increases thymidine uptake in Chinese hamster ovary cells at low glucose concentrations. , 1991, Cancer research.
[16] D. Chalbos,et al. Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis , 2007, International journal of cancer.
[17] F. Kaye,et al. Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. , 2004, Cancer cell.
[18] K. Takagishi,et al. Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-β , 2004, Laboratory Investigation.
[19] H. Lodish,et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.
[20] W. Linehan,et al. LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer , 2009, Molecular Cancer Therapeutics.
[21] H. Inoue,et al. Glucose‐transporter‐type‐I‐gene amplification correlates with Sialyl‐Lewis‐X synthesis and proliferation in lung cancer , 1997, International journal of cancer.
[22] M. Makuuchi,et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. , 2005, European journal of cancer.
[23] V. Hogan,et al. Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Expression Sensitizes Human Fibrosarcoma Cells to Oxidative Stress Leading to Cellular Senescence* , 2007, Journal of Biological Chemistry.
[24] I. Judson,et al. ZD9331: discovery to clinical development , 2005, Anti-Cancer Drugs.
[25] L. Johnson,et al. Transcriptional control elements and complex initiation pattern of the TATA‐less bidirectional human thymidylate synthase promoter , 2000, Journal of cellular biochemistry.
[26] Y. Yen,et al. Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment. , 2006, Oncology reports.
[27] M. Matuszewski,et al. Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[28] P. Hasleton,et al. The value of tumour markers in lung cancer. , 1988, British Journal of Cancer.
[29] H. Iishi,et al. Role of glucose‐6‐phosphate dehydrogenase on enhanced proliferation of pre‐neoplastic and neoplastic cells in rat liver induced by n‐nitrosomorpholine , 1989, International journal of cancer.
[30] D. Chan,et al. Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. , 2001, Cancer letters.
[31] T. Watts,et al. Acetyl‐CoA carboxylase in reuber hepatoma cells: Variation in enzyme activity, insulin regulation, and cellular lipid content , 1992, Journal of cellular biochemistry.
[32] R L Wahl,et al. An Immunohistochemical Study , 2006 .
[33] L. Sillerud,et al. Differentiation of human tumors from nonmalignant tissue by natural‐abundance 13C NMR spectroscopy , 1988, Magnetic resonance in medicine.
[34] R. Angioli,et al. GLUT‐1 expression in ovarian carcinoma , 2001, Cancer.
[35] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[36] Daniel E Bauer,et al. ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.
[37] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[38] F. Kaye,et al. Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas , 2007, Oncogene.
[39] G. Whitmore,et al. Studies relating to the mode of action of methotrexate. 3. Inhibition of thymidylate synthetase in tissue culture cells and in cell-free systems. , 1969, Molecular pharmacology.
[40] Kun-Liang Guan,et al. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.
[41] D. Chan,et al. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer. , 2004, Journal of experimental therapeutics & oncology.
[42] R. Molina,et al. Serum phosphohexose isomerase activities in patients with colorectal cancer. , 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[43] L. Jacobs,et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. You,et al. Ribonucleotide reductase small subunit p53R2 suppresses MEK–ERK activity by binding to ERK kinase 2 , 2009, Oncogene.
[45] A. Nashimoto,et al. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach , 2002, Histopathology.
[46] R. Mansel,et al. Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[47] T. Gansler,et al. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. , 1997, Human Pathology.
[48] D. Sgroi,et al. Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. , 2004, Journal of proteome research.
[49] T. Tang,et al. Effects of G6PD overexpression in NIH3T3 cells treated with tert-butyl hydroperoxide or paraquat. , 1998, Free radical biology & medicine.
[50] Y. Yen,et al. Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis , 2009, Molecular Cancer.
[51] T. Tang,et al. Human glucose‐6‐phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice , 2000, International journal of cancer.
[52] B. Dwarakanath,et al. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells , 2005, International journal of radiation biology.
[53] V. Lam,et al. GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors. , 2003, Cancer research.
[54] Ricardo Lage,et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. , 2008, Cell metabolism.
[55] K. Takata,et al. Investigative Urology: Immunohistochemical Localization of Glucose Transporters in Human Renal Cell Carcinoma , 1995 .
[56] J. Cronan. The structure of mammalian fatty acid synthase turned back to front. , 2004, Chemistry & biology.
[57] M. Brin. Effects of thiamine deficiency and of oxythiamine on rat tissue transketolase. , 1962, The Journal of nutrition.
[58] R. Jackson,et al. IMP dehydrogenase, an enzyme linked with proliferation and malignancy , 1975, Nature.
[59] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[60] M. Krockenberger,et al. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases , 2006, International Journal of Gynecologic Cancer.
[61] B. Chowbay,et al. Correspondence re: Cecchin et al., Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients. Clin Cancer Res 2005;11:6901–7 , 2006, Clinical Cancer Research.
[62] R. D. Williams,et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. , 1997, Cancer research.
[63] C. Bosman,et al. Fatty acid synthase expression in melanoma , 2003, Journal of cutaneous pathology.
[64] M. Carrasco,et al. Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues , 2006, Journal of cellular physiology.
[65] J. Christman,et al. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. , 1982, The Journal of biological chemistry.
[66] J. Kwiatkowski,et al. Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. , 1979, British Journal of Cancer.
[67] Y. Dobashi,et al. Differential expression and pathological significance of autocrine motility factor/glucose‐6‐phosphate isomerase expression in human lung carcinomas , 2006, The Journal of pathology.
[68] Chi V Dang,et al. Multifaceted roles of glycolytic enzymes. , 2005, Trends in biochemical sciences.
[69] N. Chandel,et al. Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis , 2007, Molecular and Cellular Biology.
[70] D. Heimburger,et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. , 2000, Human pathology.
[71] T. Lazar Mathew,et al. Optimizing Cancer Radiotherapy with 2-Deoxy-D-Glucose , 2005, Strahlentherapie und Onkologie.
[72] H. Grunicke,et al. Mechanism and biological significance of the Ha-ras-induced activation of the Na+/H(+)-antiporter. , 1990, Advances in enzyme regulation.
[73] M. Fukushima,et al. Significance of thymidylate synthase activity in renal cell carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[74] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[75] Zhong Zheng,et al. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. , 2007, The New England journal of medicine.
[76] A. Rashid,et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. , 1997, The American journal of pathology.
[77] Ken Saito,et al. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. , 2006, Cancer research.
[78] V. Hogan,et al. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. , 2007, Cancer research.
[79] Anne Kallioniemi,et al. Targets of gene amplification and overexpression at 17q in gastric cancer. , 2002, Cancer research.
[80] Y. Yazaki,et al. The role of N-glycosylation of GLUT1 for glucose transport activity. , 1991, The Journal of biological chemistry.
[81] M. Meuth. Sensitivity of a mutator gene in Chinese hamster ovary cell to deoxynucleoside triphosphate pool alterations , 1981, Molecular and cellular biology.
[82] Wei Kong,et al. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: A potential therapeutic target in nasopharyngeal carcinoma , 2008, Cancer biology & therapy.
[83] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[84] P. Alken,et al. Metastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer , 2008, International journal of cancer.
[85] B. Meldrum,et al. ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE , 1973, Journal of neurochemistry.
[86] B. Ebert,et al. Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*) , 1995, The Journal of Biological Chemistry.
[87] H. Morris,et al. Increased DNA polymerase activity in a series of rat hepatomas. , 1969, Cancer research.
[88] Y. Ahn,et al. Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas , 2004, Virchows Archiv.
[89] H. Lehrach,et al. A catabolic block does not sufficiently explain how 2-deoxy-d-glucose inhibits cell growth , 2008, Proceedings of the National Academy of Sciences.
[90] R. Moreno-Sánchez,et al. Energy metabolism transition in multi‐cellular human tumor spheroids , 2008, Journal of cellular physiology.
[91] Katarzyna D Arczewska,et al. Bacterial DNA repair genes and their eukaryotic homologues: 2. Role of bacterial mutator gene homologues in human disease. Overview of nucleotide pool sanitization and mismatch repair systems. , 2007, Acta biochimica Polonica.
[92] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[93] Lijun Xue,et al. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation. , 2007, Cancer research.
[94] Yun Yen,et al. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential , 1998, Clinical & Experimental Metastasis.
[95] C. Thompson,et al. ATP citrate lyase is an important component of cell growth and transformation , 2005, Oncogene.
[96] G. Bepler,et al. RRM1-induced metastasis suppression through PTEN-regulated pathways , 2003, Oncogene.
[97] Magnus Hellström,et al. Proteomic analysis of protein expression in prostate cancer. , 2005, Analytical and quantitative cytology and histology.
[98] A. Harris,et al. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. , 2001, Cancer research.
[99] R. Minami,et al. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. , 2001, European journal of cancer.
[100] J. Wright,et al. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[101] Okio Hino,et al. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. , 2005, Cancer research.
[102] R. Gelber,et al. Prognostic importance of thymidylate synthase expression in early breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[104] W. Hahn,et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. , 2009, Journal of the National Cancer Institute.
[105] T. Huh,et al. Cytosolic NADP+-dependent Isocitrate Dehydrogenase Plays a Key Role in Lipid Metabolism* , 2004, Journal of Biological Chemistry.
[106] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[107] S. Larson,et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. , 1999, American journal of surgery.
[108] G. Bepler,et al. Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase. , 2006, Cancer research.
[109] Timm Maier,et al. Architecture of Mammalian Fatty Acid Synthase at 4.5 Å Resolution , 2006, Science.
[110] T. Roskams,et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer , 2002, International journal of cancer.
[111] K. Brand,et al. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. , 1990, Cancer investigation.
[112] G. Semenza,et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.
[113] Mark E. Davis,et al. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA , 2007, Proceedings of the National Academy of Sciences.
[114] J. H. Kim,et al. Regulation of glucose metabolism-related genes and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer , 2009, Experimental & Molecular Medicine.
[115] L. Liotta,et al. Tumor cell autocrine motility factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[116] L. Witters,et al. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[117] R. Shigemoto,et al. Distribution of the glucose transporters in human brain tumors. , 1992, Cancer research.
[118] Y. Ishikawa,et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. , 2008, Cancer research.
[119] R. Stroud,et al. Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site. , 1995, Biochemistry.
[120] H. Kuwano,et al. Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis , 2004, Clinical Cancer Research.
[121] F. López-Ríos,et al. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas. , 2007, Human pathology.
[122] D. Burstein,et al. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia , 2000, Cancer.
[123] R. Supino,et al. A qualitative and quantitative cytochemical assay of dihydrofolate reductase in erythroid cells. , 1989, Acta histochemica.
[124] J. Wright,et al. The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[125] A W Partin,et al. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. , 1995, Urology.
[126] Timm Maier,et al. The Crystal Structure of a Mammalian Fatty Acid Synthase , 2008, Science.
[127] P. Leder,et al. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.
[128] I. Nabi,et al. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. , 2003, Cancer research.
[129] T. Schulz,et al. Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth , 2006, Journal of Biological Chemistry.
[130] G. Lenoir,et al. Acetyl-CoA Carboxylase α Is Essential to Breast Cancer Cell Survival , 2006 .
[131] R. Bronson,et al. Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms. , 2008, Cancer research.
[132] Yong-Ho Ahn,et al. Up-regulation of Acetyl-CoA Carboxylase α and Fatty Acid Synthase by Human Epidermal Growth Factor Receptor 2 at the Translational Level in Breast Cancer Cells* , 2007, Journal of Biological Chemistry.
[133] D. Burstein,et al. GLUT1 glucose transporter expression in colorectal carcinoma , 1998, Cancer.
[134] G. Kong,et al. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. , 2007, Toxicology and applied pharmacology.
[135] I. Fabregat,et al. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. , 2006, Carcinogenesis.
[136] G. Semenza,et al. Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.
[137] Xiaojun Xu,et al. Transketolase‐like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells , 2009, International journal of cancer.
[138] J. Koudstaal,et al. Enzyme histochemical pattern in human tumours. II. Oxidoreductases in carcinoma of the colon and the breast. , 1975, European journal of cancer.
[139] Justin R. Cross,et al. ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation , 2009, Science.
[140] Johnathan C. Maher,et al. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. , 2007, Antioxidants & redox signaling.
[141] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[142] C. Leichman. Predictive and prognostic markers in gastrointestinal cancers , 2001, Current opinion in oncology.
[143] M. Younes,et al. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[144] T Shinozaki,et al. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.
[145] M. Duxbury,et al. RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness. , 2007, Biochemical and biophysical research communications.
[146] H. Morris,et al. Increased cytidine 5'-triphosphate synthetase activity in rat and human tumors. , 1980, Cancer research.
[147] S. Tsukagoshi,et al. Enhanced Expression of Thymidylate Synthase May Be of Prognostic Importance in Advanced Cervical Cancer , 1999, Oncology.
[148] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[149] P. Visca,et al. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. , 2004, Gynecologic oncology.
[150] Ying Wang,et al. FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis , 2005, Oncogene.
[151] L. Liotta,et al. Detection of autocrine motility factor in urine as a marker of bladder cancer. , 1988, Journal of the National Cancer Institute.
[152] J. Kalbfleisch,et al. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. , 1996, Human pathology.
[153] D. Calvisi,et al. Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats , 2004, International journal of cancer.
[154] P. Visca,et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients , 1996, Cancer.
[155] E. Takeda,et al. Role of ribonucleotide reductase in expression in the neoplastic program. , 1981, Life sciences.
[156] F. López-Ríos,et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. , 2007, Cancer research.
[157] S. Morgello,et al. Tissue distribution of the human GLUT3 glucose transporter. , 1993, Endocrinology.
[158] Y. Mo,et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. , 2008, Cancer research.
[159] M Cascante,et al. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. , 2001, European journal of biochemistry.
[160] S. Baer,et al. Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia. , 1997, Journal of the American Academy of Dermatology.
[161] M. C. Rudolph,et al. Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! , 2007, Breast Cancer Research.
[162] S. Miyoshi,et al. New prognostic indicator for non‐small‐cell lung cancer, quantitation of thymidylate synthase by real‐time reverse transcription polymerase chain reaction , 2003, International journal of cancer.
[163] Ziwei Gu,et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[164] T. Osborne,et al. Proto-oncogene FBI-1 (Pokemon) and SREBP-1 Synergistically Activate Transcription of Fatty-acid Synthase Gene (FASN)* , 2008, Journal of Biological Chemistry.
[165] H. Nisenbaum,et al. HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.
[166] Li-hua Hu,et al. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells , 2007, Anti-cancer drugs.
[167] Mohit M. Jain,et al. Long-Term Effects of Increased Glucose Entry on Mouse Hearts During Normal Aging and Ischemic Stress , 2007, Circulation.
[168] J. Eble,et al. Increased thymidylate synthase (EC 2.1.1.45) activity in normal and neoplastic proliferation. , 1988, Cancer biochemistry biophysics.
[169] C. Burant,et al. Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins. , 1992, Biochemistry.
[170] J. Brunet,et al. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells , 2008, Cell proliferation.
[171] M. Bogdonoff,et al. The effect of 2-deoxy-D-glucose infusions on lipid and carbohydrate metabolism in man. , 1961, The Journal of clinical investigation.
[172] X. Wang,et al. Regulation of p53R2 and its role as potential target for cancer therapy. , 2009, Cancer letters.
[173] S. Schreiber,et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[174] Jeffrey W. Smith,et al. Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.
[175] M. Nakagawa,et al. Clinical significance of thymidylate synthase expression in bladder cancer , 2002, International journal of urology : official journal of the Japanese Urological Association.
[176] Kazutomo Inoue,et al. Over-expression of facilitative glucose transporter genes in human cancer. , 1990, Biochemical and biophysical research communications.
[177] E. Gabrielson,et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. , 2003, Experimental cell research.
[178] H. Korman,et al. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder. , 1996, The Journal of urology.
[179] A. Figer,et al. The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings , 2007, Journal of Gastrointestinal Surgery.